Scientific Commons: P. Durez

Four year follow-up of infliximab in rheumatoid arthritis patients refractory to multiple dmard treatment: Long-term clinical effect and prediction of attrition (2006)

Vander Cruyssen, Bert, WESTHOVENS, R, DUREZ, P, Van Den Bosch, Filip, Mielants, Herman, DE CLERCK, L, ...

Four-year follow-up of infliximab therapy in rheumatoid arthritis patients with long-standing refractory disease: attrition and long-term evolution of disease activity (2006)

Vander Cruyssen, Bert, Van Looy, Stijn, Wyns, Bart, WESTHOVENS, R, DUREZ, P, Van Den Bosch, Filip, ...

Prediction of dose escalation for rheumatoid arthritis patients under infliximab treatment (2006)

Van Looy, Stijn, Vander Cruyssen, Bert, Meeus, Jeroen, Wyns, Bart, WESTHOVENS, R, DUREZ, P, ...

Detection of vertebral fractures on routine chest rays: The stof study (2006)

GOEMAERE, STEFAN, BOUTSEN, Y, DUREZ, P, VANSLEMBROUCK, J, NISOLLE, JF, Verstraete, Koenraad, ...

Healthcare consumption and direct costs of rheumatoid arthritis in Belgium (2005)

Boonen, A, Verbruggen, L, Durez, P, De Clerck, L, Malaise, M, ...

The aim of this study was to compare the socioeconomic consequences of early and late rheumatoid arthritis in Belgium and to assess the patient out-of-pocket contributions. This multicentre...

DAS28 best reflects the physician's clinical judgment of response to infliximab therapy in rheumatoid arthritis patients: validation of the DAS28 score in patients under infliximab treatment (2005)

Cruyssen, B, Van Looy, S, Wyns, B, Westhovens, R, Durez, P, Malaise, M, ...

This study is based on an expanded access program in which 511 patients suffering from active refractory rheumatoid arthritis (RA) were treated with intravenous infusions of infliximab (3 mg/kg+...

Das28 correlates best with the physician's clinical judgment of response to infliximab therapy in rheumatoid arthritis patients (2005)

Vander Cruyssen, Bert, Van Looy, Stijn, WESTHOVENS, R, DUREZ, P, Van Den Bosch, Filip, VEYS, EM, ...

Healthcare consumption and direct costs of rheumatoid arthritis in Belgium (2005)

WESTHOVENS, R, BOONEN, A, VERBRUGGEN, L, DUREZ, P, DE CLERCK, L, MALAISE, M, ...

DAS28 best reflects the physician's clinical judgment of response to infliximab therapy in rheumatoid arthritis patients: validation of the DAS28 score in patients under infliximab treatment (2005)

Vander Cruyssen, Bert, Van Looy, Stijn, Wyns, Bart, WESTHOVENS, R, DUREZ, P, MALAISE, M, ...

DAS28 is a robust measure of the physician's clinical judgment of response infliximab therapy (2005)

Vander Cruyssen, Bert, Van Looy, Stijn, Wyns, Bart, WESTHOVENS, R, DUREZ, P, ...

A dose adjustment in patients with rheumatoid arthritis not optimally responding to a standard dose of infliximab of 3 mg/kg every 8 weeks can be effective: a Belgian prospective study (2005)

Durez, P., Corluy, L., Veys, E. M., De Clerck, L., Peretz, A., ...

Objectives. To analyse the effect of a dose increase in patients with severe rheumatoid arthritis (RA) with insufficient clinical response to 3 mg/kg infliximab every 8 weeks. Methods. Patients...

A dose adjustment in patients with rheumatoid arthritis not optimally responding to a standard dose of infliximab of 3 mg/kg every 8 weeks can be effective: a Belgian prospective study (2005)

Durez, P., Corluy, L., Veys, E. M., Clerck, L. De, Peretz, A., ...

Objectives. To analyse the effect of a dose increase in patients with severe rheumatoid arthritis (RA) with insufficient clinical response to 3 mg/kg infliximab every 8 weeks. Methods. Patients...

Timing of DAS28 in infliximab therapy: reply (2005)

Durez, P., Corluy, L., Veys, E., De Clerck, L., Peretz, A., ...

Timing of DAS28 in infliximab therapy: reply (2005)

Durez, P., Corluy, L., Veys, E., De Clerck, L., Peretz, A., ...

Autologous Hemopoietic Stem Cell Transplantation in Severe Rheumatoid Arthritis: A Report from the EBMT and ABMTR (2004)

Snowden, JA, Passweg, J, Moore, JJ, Milliken, S, Cannell, P, Van Laar, JM, ...

Objective. Since 1996, autologous hemopoietic stem cell transplantation (HSCT) has been used to treat severe rheumatoid arthritis (RA). To date, published reports have been individual cases or series...

Autologous Hemopoietic Stem Cell Transplantation in Severe Rheumatoid Arthritis: A Report from the EBMT and ABMTR (2004)

Snowden, JA, Passweg, J, Moore, JJ, Milliken, S, Cannell, P, Van Laar, JM, ...

Tumour necrosis factor alpha independent disease mechanisms in rheumatoid arthritis: a histopathological study on the effect of infliximab on rheumatoid nodules (2004)

Baeten, Dominique, De Keyser, Filip, Veys, Eric, THEATE, Y, HOUSSIAU, FA, DUREZ, P

Autologous Hemopoietic Stem Cell Transplantation in Severe Rheumatoid Arthritis: A Report from the EBMT and ABMTR (2004)

Snowden, J. A., Passweg, J., Moore, J. J., Milliken, S., Cannell, P., Van Laar, J. M., ...

Objective. Since 1996, autologous hemopoietic stem cell transplantation (HSCT) has been used to treat severe rheumatoid arthritis (RA). To date, published reports have been individual cases or series...

Autologous stem cell transplantation in rheumatoid arthritis (2001)

Snowden, JA, Moore, J, Passweg, JR, Cannell, P, Van Laar, J, Bingham, S, ...

Role of interleukin-4 and interleukin-10 in murine collagen-induced arthritis: protective effect of interleukin-4 and interleukin-10 treatment on cartilage destruction (1997)

Goldman, M., Jacobs, H.J.M., Helsen, M.M.A., Durez, P., Lubberts, G.J.H., ...

Articular aspergillosis: two case reports and review of the literature (1997)

Steinfeld, S, Durez, P, Hauzeur, JP, Motte, S, Appelboom, T

Hepatitis C virus and its genotypes in patients suffering from chronic hepatitis C with or without a cryoglobulinemia-related syndrome (1995)

Sheng, L, Ramdani, B, Doutrelepont, J M, ...

Recently, evidence has been presented for a possible association between hepatitis C virus (HCV) infection and essential mixed cryoglobulinemia (EMC). Eleven consecutive patients with EMC and two...

Hepatitis C infection and membranoproliferative glomerulonephritis (1993)

Adler, M, Durez, P

Effect of milk product deprivation on spondyloarthropathy.

Appelboom, T, Durez, P

Tumour necrosis factor α independent disease mechanisms in rheumatoid arthritis: a histopathological study on the effect of infliximab on rheumatoid nodules

Baeten, D, De Keyser, F, Veys, E, Theate, Y, Houssiau, F, Durez, P

Background: It has been suggested that the immunopathology of rheumatoid nodules parallels that of inflamed synovium in rheumatoid arthritis (RA).

A randomised comparative study of the short term clinical and biological effects of intravenous pulse methylprednisolone and infliximab in patients with active rheumatoid arthritis despite methotrexate treatment

Durez, P, Nzeusseu, T, Lauwerys, B, Manicourt, D, Verschueren, P, Westhovens, R, ...

Objectives: To compare the short term clinical and biological effects of intravenous (IV) pulse methylprednisolone (MP) and infliximab (IFX) in patients with severe active rheumatoid arthritis (RA)...

Which dose regimen for glucocorticoid pulse therapy in patients with severe refractory RA?

Buttgereit, F, Burmester, G, Bijlsma, J, Durez, P, Nzeusseu, T, Lauwerys, B, ...

Is IV infliximab better than IV methylprednisolone for the treatment of patients with RA when methotrexate fails?

Smith, M, Durez, P, Nzeusseu, T, Lauwerys, B, Manicourt, D, Devogelaer, J, ...

The 6-month safety and efficacy of abatacept in patients with rheumatoid arthritis who underwent a washout after anti-tumour necrosis factor therapy or were directly switched to abatacept: the ARRIVE trial

Schiff, M, Pritchard, C, Huffstutter, J E, Rodriguez-Valverde, V, Durez, P, Zhou, X, ...

P. Durez

Publication List Details